HIV / AIDS in the News

Vaccine shows promise in curing HIV, Hong Kong start-up says - South China Morning Post

 

Fast Facts: HIV in the US by Age - CDC

 

Patient dies, 30 others test positive for HIV at Nishtar’s dialysis unit in Multan - DAWN.com

 

Patient dies, 30 others test positive for HIV at Nishtar’s dialysis unit - DAWN.com

 

UNM researcher is advancing HIV Prevention and Health Equity for Native Americans - Albuquerque Journal

 

Report: Nursing home failed to give resident HIV medication for 3 weeks, documented administering it anyway - CBS 6 News Richmond WTVR

 

A significant number of people in the Caribbean die annually from HIV-related causes — PAHO - Jamaica Observer

 

From UHC2030 to sustained HIV services: Considerations for integrating HIV and strengthened primary health care systems - PATH

 

Gilead data lends insight into transforming HIV prevention landscape - European Pharmaceutical Review

 

Risk factors for surgical site infection after general surgery in HIV-infected patients: a retrospective study - BMC Infectious Diseases

 

Coastal Health District Hosts HIV Testing Events for World AIDS Day - Georgia Coastal Health District

 

Accessible Testing for All - Inside Precision Medicine

 

World AIDs Day: Coastal Health District to offer free HIV testing events in Savannah - AOL

 

Two-Drug Regimen Works Well for People With Advanced HIV - POZ

 

Guest Opinion: AIDS orgs may not survive to see the end of the pandemic - Bay Area Reporter, America's highest circulation LGBT newspaper

 

Gilead reports positive HIV PrEP data for lenacapavir (NASDAQ:GILD) - Seeking Alpha

 

Gilead reports positive HIV PrEP data for lenacapavir (NASDAQ:GILD) - Seeking Alpha

 

Free HIV testing in North Georgia on Dec. 3 - Daily Tribune News

 

CDC numbers offer good news on HIV infections overall but reveal a crisis for Latinos | Opinion - Miami Herald

 

Novel Weekly Oral HIV Drug Safe in Early Trial of Healthy Volunteers - Medpage Today

 

Lenacapavir for PrEP Demonstrates Strong Efficacy, Adherence in Phase 3 Trial - Drug Topics

 

PAHO: Significant number of people in Caribbean die annually from HIV-related causes - Trinidad Guardian

 

Egypt and Global Fund Sign Agreement to Combat HIV and tuberculosis - Egyptian Streets

 

Gilead Sciences (GILD) Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention - StreetInsider.com

 

Gilead's HIV Prevention Drug Shows 96% Success Rate in Breakthrough Trial Results | GILD Stock News - StockTitan

 

Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow - Business Wire

 

From Fear to Hope: The HIV & Aids Journey Screening and Conversation - Miami's Community Newspapers

 

Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV - BioSpace

 

Inhibiting HIV by Host Cell Targeting Strategies - amfAR, The Foundation for AIDS Research

 

New Asia Pacific healthcare provider toolkit serves people having chemsex - UNAIDS